Childhood absence epilepsy (CAE) is a hereditary disorder that involves the onset of frequent absence seizures – temporary losses of focus/awareness, and sometimes involving unintentional staring. Some affected children also experience repetitive movements, along with attention, concentration, and memory problems.
Seizures usually begin between the ages of 2 and 12, although most commonly, they appears between ages 5 and 8. Each absence seizure typically lasts between 10 and 20 seconds and ends abruptly. They often occur during exercise, and children may have between 1 and 100 of these seizures a day. CAE is a generalized idiopathic epilepsy, meaning the onset is sudden and without any prior medical warning or certain cause.
Susceptibility to childhood absence epilepsy 2 (CAE2) is thought to be linked to a mutation (change) in the GABRG2 gene. The GABRG2 gene is passed on in an autosomal dominant pattern, meaning only one parent has to have the mutated GABRG2 gene for their child to have a change of having CAE.
CAE diagnosis usually involves an examination of symptoms and family health history. An EEG may be done to examine brain electrical activity and to further confirm the diagnosis. Genetic testing may be an option to identify the mutated GABRG2 gene.
There is no cure for CAE – most children with CAE no longer have seizures by the time they reach adolescence. Treatment for absence seizures may include anticonvulsant medications. Some children may be prescribed a ketogenic diet if they do not respond to treatment by medication. A small percentage of children with this condition will develop other types of seizures in adolescence.
If you or a family member has been diagnosed with CAE, speak with your doctor to learn more information. Support groups may also be available for further resources.
Description Last Updated: Aug 22, 2018